Canadian application, no grantCanada
Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors
CA 2425910 A1 · Owner: Dinan, T. G. · Inventors: Dinan, T. G.; Keeling, P. W. N.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for preventing and treating gastrointestinal diseases such as dyspepsia irritable bowel disease and , chemotherapy-associated nausea by administering an antagonist or partial agonist of 5HT1a receptors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 11, 2001
GrantedNo grant recorded
Term endedOctober 11, 2021
Patent numberCA 2425910 A1
Classification (IPC)A61K31/00 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.